Clinical Kidney Journal,
Journal Year:
2023,
Volume and Issue:
17(1)
Published: Nov. 13, 2023
Abstract
The
prevalence
of
obesity
has
tripled
over
the
past
five
decades.
Obesity,
especially
visceral
obesity,
is
closely
related
to
hypertension,
increasing
risk
primary
(essential)
hypertension
by
65%–75%.
Hypertension
a
major
factor
for
cardiovascular
disease,
leading
cause
death
worldwide,
and
its
rapidly
following
pandemic
rise
in
obesity.
Although
causal
relationship
between
high
blood
pressure
(BP)
well
established,
detailed
mechanisms
such
association
are
still
under
research.
For
more
than
30
years
sympathetic
nervous
system
(SNS)
kidney
sodium
reabsorption
activation,
secondary
insulin
resistance
compensatory
hyperinsulinemia,
have
been
considered
as
mediators
elevated
BP
However,
experimental
clinical
data
show
that
severe
hyperinsulinemia
can
occur
absence
BP,
challenging
key
linking
hypertension.
purpose
Part
1
this
review
summarize
available
on
recently
emerging
believed
contribute
obesity-related
through
increased
volume
expansion,
as:
physical
compression
perirenal/intrarenal
fat
overactivation
systemic/renal
SNS
renin–angiotensin–aldosterone
system.
role
hyperleptinemia,
impaired
chemoreceptor
baroreceptor
reflexes,
perivascular
also
discussed.
Specifically
targeting
these
may
pave
way
new
therapeutic
intervention
treatment
context
‘precision
medicine’
principles,
which
will
be
discussed
2.
Cardiovascular Diabetology,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Aug. 22, 2024
The
triglyceride-glucose
(TyG)
index
and
estimated
glucose
disposal
rate
(eGDR),
which
are
calculated
using
different
parameters,
widely
used
as
markers
of
insulin
resistance
associated
with
cardiovascular
diseases
prognosis.
However,
whether
they
have
an
additive
effect
on
the
risk
mortality
remains
unclear.
This
study
aimed
to
explore
combined
assessment
TyG
eGDR
improved
prediction
long-term
in
individuals
without
diabetes.
In
this
cross-sectional
cohort
study,
data
were
derived
from
National
Health
Nutrition
Examination
Survey
(NHANES)
2001–2018,
death
record
information
was
obtained
Death
Index.
associations
all-cause
determined
by
multivariate
Cox
regression
analysis
restricted
cubic
splines.
Among
17,787
included
analysis,
there
1946
(10.9%)
deaths
649
(3.6%)
during
a
median
follow-up
8.92
years.
diabetes,
spline
curves
for
followed
J-shape
L-shape,
respectively.
significantly
increased
after
>
9.04
(all-cause
mortality)
or
9.30
(cardiovascular
mortality),
<
4
mg/kg/min
(both
mortality).
association
between
negative
linear
relationship.
no
mortality.
Compared
low
high
group,
those
group
(TyG
4)
showed
highest
(hazard
ratio
[HR]
=
1.592,
95%
confidence
interval
[CI]
1.284–1.975)
(HR
1.683,
CI
1.179-2.400)
overall
population.
Similar
results
observed
There
potential
provided
additional
prognostic
contributed
improving
stratification.
Cardiovascular Diabetology,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: May 13, 2024
Abstract
Background
The
relationship
between
the
triglyceride–glucose
(TyG)
index
and
risk
of
cardiovascular
disease
(CVD)
in
U.S.
population
under
65
years
age
with
diabetes
or
prediabetes
is
unknown.
purpose
this
study
was
to
investigate
baseline
TyG
CVD
patients
prediabetes.
Methods
We
used
data
from
2003–2018
National
Health
Nutrition
Examination
Survey
(NHANES).
Multivariate
regression
analysis
models
were
constructed
explore
risk.
Nonlinear
correlations
explored
using
restricted
cubic
splines.
Subgroup
interaction
tests
also
conducted.
Results
enrolled
a
total
4340
participants
pre-diabetes,
mean
9.02
±
0.02.
overall
average
prevalence
10.38%.
Participants
higher
quartiles
showed
high
rates
(Quartile
1:
7.35%;
Quartile
2:
10.04%;
3:
10.71%;
4:
13.65%).
For
CVD,
possible
association
observed.
Our
findings
suggested
linear
CVD.
results
revealed
U-shaped
both
(P
nonlinear
=
0.02583)
CHF
0.0208)
individuals
diabetes.
term
indicated
that
there
no
significant
difference
among
different
stratifications.
positive
comorbid
MetS
Conclusions
A
linked
an
increased
likelihood
aged
≤
Besides,
assessment
will
contribute
more
convenient
effective
screening
high-risk
MetS.
Future
studies
should
whether
interventions
targeting
may
improve
clinical
outcomes
these
patients.
Cardiovascular Diabetology,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 8, 2025
Among
hypertensive
cohorts
across
different
nations,
the
relationship
between
triglyceride-glucose
index
(TyG)
and
its
conjunction
with
obesity
metrics
in
relation
to
cardiovascular
disease
(CVD)
incidence
mortality
remains
be
elucidated.
This
study
enrolled
9,283,
164,357,
5,334
hypertensives
from
National
Health
Nutrition
Examination
Survey
(NHANES),
UK
Biobank
(UKBB),
Shanghai
Pudong
cohort.
The
related
outcomes
for
CVD
were
defined
by
multivariate
Cox
proportional
hazards
models,
Generalized
Additive
Models
Mendelian
randomization
analysis.
Mediation
analysis
explored
mediating
role
of
inflammatory
markers
above
relationships.
Five
measures
insulin
resistance
linked
death
a
U-shaped
pattern,
highest
group
having
risk
increases.
Higher
glucose
triglyceride-waist
height
ratio
(TyG-WHTR)
was
higher
all-cause
(UKBB:
HR
1.21,
95%CI
1.16–1.26,
NHANES:
1.17,
1.00–1.36),
1.36,
1.23–1.49,
1.32,
1.00–1.72)
risks.
In
China
cohort,
triglyceride/high-density
lipoprotein-cholesterol
(TG/HDL_C)
associated
risks
stroke
(HR
1.31,
1.00–1.73
1.67,
1.06–2.63).
Inflammation
like
systemic
response
(SIRI)
C-reactive
protein
(CRP)
partially
explained
these
links,
CRP
stronger
effect.
Genetically
predicted
TyG
also
(OR
1.26,
1.10–1.45)
risk.
An
elevated
indices
are
significantly
correlated
an
increased
three
national
cohorts.
These
anticipated
serve
as
valid
predictors
incident
individuals
hypertension.
The
triglyceride
glucose-body
mass
index
(TyG-BMI)
is
considered
to
be
a
reliable
surrogate
marker
of
insulin
resistance
(IR).
However,
limited
evidence
exists
regarding
its
association
with
the
severity
coronary
artery
disease
(CAD),
particularly
in
hypertensive
patients
different
glucose
metabolic
states,
including
those
H-type
hypertension.
This
study
aimed
investigate
relationship
between
TyG-BMI
and
CAD
across
metabolism
conditions.
retrospective
cohort
included
1537
who
underwent
angiography.
was
categorized
into
tertiles
analyzed
using
logistic
regression
models
restricted
cubic
spline
(RCS)
assess
multi-vessel
CAD.
Receiver
operating
characteristic
(ROC)
curves
were
used
evaluate
predictive
value
detecting
normal
regulation
(NGR),
pre-diabetes
mellitus
(Pre-DM),
diabetes
(DM).
above
method
has
also
been
applied
populations
hypertension
patients.
significantly
associated
(Odds
ratio
[OR]
1.043,
95%
CI
1.032–1.053).
In
diabetic
subgroup,
after
adjusting
for
risk
factors,
T3
groups
3.836-fold
(95%
1.763–8.347;
P
=
0.001)
higher
than
T1
group,
non-linear
dose–response
(P
non-linearity
0.017).
patients,
correlated
(OR
5.248,
1.821–15.126,
0.002)
DM
group.
ROC
analysis
revealed
that
had
highest
an
AUC
0.720
0.661–0.780,
<
0.001).
serves
as
robust
predictor
And
underscores
potential
clinical
utility.
could
serve
valuable
tool
early
identification
individuals
at
high
risk.
Insulin
resistance
is
a
crucial
factor
in
the
development
of
cardiovascular
diseases
(CVD),
yet
relationship
between
estimated
glucose
disposal
rate
(eGDR),
an
index
reflecting
insulin
resistance,
and
risk
new-onset
CVD
among
individuals
with
cardiovascular-kidney-metabolic
(CKM)
syndrome
stage
0–3
remains
underexplored,
large-scale
prospective
cohort
studies
are
needed
to
clarify
this
relationship.
All
data
for
study
were
extracted
from
China
Health
Retirement
Longitudinal
Study
(CHARLS).
The
primary
outcome
was
incidence
(including
heart
(HD)
stroke)
during
follow-up
period
(from
2013
2020).
Multivariable
logistic
regression
models
applied
elucidate
eGDR
developing
CVD.
restricted
cubic
splines
(RCS),
mediation
analysis,
stratified
analyses
also
employed.
This
included
6752
participants,
whom
1495
(22%)
developed
Odds
ratios
95%
confidence
intervals
lowest
level
(<7.37
mg/kg/min)
highest
(≥
11.16
1.00
(reference),
0.81
(0.68,
0.96),
0.72
(0.58,
0.88),
0.74
0.94)
respectively,
occurrence
CVD;
(0.67,0.97),
(0.57,0.90),
0.75
(0.58,0.97)
HD;
0.91
(0.74,1.12),
0.80
(0.62,1.04),
0.71
(0.52,0.97)
stroke
after
adjusting
all
potential
covariates.
RCS
analysis
discovered
approximately
inverse
"L"
correlation
HD
across
CKM
stages
(All
P
overall
<
0.001,
nonlinear
=
0.005),
while
there
negative
linear
(P
0.026,
0.098).
Furthermore,
proportions
mediated
through
BMI
41.98%,
43.05%,
43.23%
CVD,
stroke,
respectively.
No
significant
interactions
found.
novel
indicator
0–3,
serving
as
partial
mediator
association
risk.
Addressing
may
represent
viable
strategy
reducing
population.
Frontiers in Cardiovascular Medicine,
Journal Year:
2021,
Volume and Issue:
8
Published: May 31, 2021
Background:
Triglyceride-glucose
(TyG)
index
is
a
recently
proposed
surrogate
indicator
of
insulin
resistance.
Previous
studies
evaluating
the
association
between
TyG
and
hypertension
risk
in
general
adult
population
showed
inconsistent
results.
We
performed
meta-analysis
to
systematically
evaluate
this
association.
Methods:
Observational
studies,
which
evaluated
independent
population,
were
identified
by
systematic
search
PubMed,
Embase,
Web
Science,
Wanfang
data,
Chinese
National
Knowledge
Infrastructure
databases.
A
random-effect
model,
incorporated
potential
intra-study
heterogeneity,
was
used
for
meta-analysis.
Results:
Eight
observational
including
200,044
participants
included.
Results
that
compared
with
those
lowest
category
index,
subjects
highest
associated
higher
odds
[adjusted
ratio
(RR):
1.53,
95%
confidence
interval
(CI):
1.26–1.85,
I
2
=
54%,
P
<
0.001].
Sensitivity
analysis
excluding
one
dataset
at
time
consistent
result
(adjusted
RR:
1.44–1.62,
all
0.001).
univariate
meta-regression
differences
sample
size,
mean
age,
male
proportion,
body
mass
study
quality
score
among
included
did
not
have
significant
influence
on
(
values
>
0.10),
suggesting
these
characteristics
may
be
major
source
heterogeneity.
Subgroup
analyses
such
as
design,
participant
ethnicity,
or
sex
significantly
affect
subgroup
difference
>0.05).
Conclusions:
Higher
population.
Large-scale
prospective
cohort
are
needed
validate
findings,
further
elucidate
pathophysiological
mechanisms
underlying
hypertension.
Cardiovascular Diabetology,
Journal Year:
2021,
Volume and Issue:
20(1)
Published: Nov. 6, 2021
Abstract
Type
2
diabetes
is
one
of
the
most
relevant
risk
factors
for
heart
failure,
prevalence
which
increasing
worldwide.
The
aim
review
to
highlight
current
perspectives
pathophysiology
failure
as
it
pertains
type
diabetes.
This
summarizes
proposed
mechanistic
bases,
explaining
myocardial
damage
induced
by
diabetes-related
stressors
and
other
factors,
i.e.,
cardiomyopathy
in
We
complex
pathology
individuals
with
diabetes,
including
relationship
chronic
kidney
disease,
metabolic
alterations,
failure.
also
discuss
criteria
used
diagnosis
gold
standard
screening
tools
Currently
approved
pharmacological
therapies
primary
use
treatment-guiding
role
NT-proBNP
are
presented.
Finally,
influence
presence
well
on
COVID-19
severity
briefly
discussed.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(20), P. 12305 - 12305
Published: Oct. 14, 2022
The
World
Health
Organization
(WHO)
refers
to
obesity
as
abnormal
or
excessive
fat
accumulation
that
presents
a
health
risk.
Obesity
was
first
designated
disease
in
2012
and
since
then
the
cost
burden
of
have
witnessed
worrisome
increase.
hypertension
are
closely
interrelated
abdominal
interferes
with
endocrine
immune
systems
carries
greater
risk
for
insulin
resistance,
diabetes,
hypertension,
cardiovascular
disease.
Many
factors
at
interplay
between
hypertension.
They
include
hemodynamic
alterations,
oxidative
stress,
renal
injury,
hyperinsulinemia,
sleep
apnea
syndrome
leptin-melanocortin
pathway.
Genetics,
epigenetics,
mitochondrial
also
play
major
role.
measurement
blood
pressure
obese
patients
requires
an
adapted
cuff
search
other
secondary
causes
is
necessary
higher
thresholds
than
general
population.
Lifestyle
modifications
such
diet
exercise
often
not
enough
control
obesity,
so
far,
bariatric
surgery
constitutes
most
reliable
method
achieve
weight
loss.
Nonetheless,
emergence
new
agents
Semaglutide
Tirzepatide
offers
promising
alternatives.
Finally,
several
molecular
pathways
actively
being
explored,
they
should
significantly
extend
treatment
options
available.
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: June 23, 2022
Metabolic
syndrome
(MetS)
includes
visceral
obesity,
hyperglycemia,
dyslipidemia,
and
hypertension.
The
prevalence
of
MetS
is
20-25%,
which
an
important
risk
factor
for
chronic
kidney
disease
(CKD).
causes
effects
on
renal
pathophysiology,
including
glomerular
hyperfiltration,
RAAS,
microalbuminuria,
profibrotic
factors
podocyte
injury.
This
review
compares
several
criteria
analyzes
their
differences.
the
pathogenesis
CKD
insulin
resistance,
inflammation,
oxidative
stress,
endothelial
dysfunction.
intervention
MetS-related
damage
focus
this
article
controlling
body
weight,
hypertension,
hyperlipidemia,
requiring
all
components
to
meet
criteria.
In
addition,
interventions
such
as
endoplasmic
reticulum
gut
microbiota,
metabolism,
appetite
inhibition,
apoptosis,
mesenchymal
stem
cells
are
reviewed.